Kairos Pharma, Ltd.
KAPA
$0.48
-$0.01-2.05%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 253.07% | 73.30% | 14,347.62% | 8,940.00% | 1,267.74% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 34.21% | 140.00% | 417.65% | 189.47% | 375.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -70.44% | -30.23% | -- | -- | -- |
| Total Current Assets | 29.22% | 40.36% | 12,634.21% | 10,154.24% | 4,027.72% |
|
|
|||||
| Total Current Assets | 29.22% | 40.36% | 12,634.21% | 10,154.24% | 4,027.72% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -72.07% | -61.07% | -52.98% | -46.78% | -41.88% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -20.77% | -- | 145.22% | 198.60% | 185.68% |
| Total Assets | 13.38% | 61.19% | 547.86% | 716.56% | 497.72% |
|
|
|||||
| Total Accounts Payable | -79.94% | -73.73% | -76.70% | -70.32% | -58.68% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -79.94% | -75.96% | -77.52% | -70.36% | -58.75% |
|
|
|||||
| Total Current Liabilities | -79.94% | -75.96% | -77.52% | -70.36% | -58.75% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -79.94% | -75.96% | -81.65% | -76.13% | -67.40% |
|
|
|||||
| Common Stock & APIC | 51.59% | 84.12% | 323.22% | 304.57% | 228.76% |
| Retained Earnings | -61.79% | -64.61% | -69.40% | -54.20% | -41.90% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 32.77% | 130.01% | 325.96% | 397.04% | 329.84% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 32.77% | 130.01% | 325.96% | 397.04% | 329.84% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 32.77% | 130.01% | 325.96% | 397.04% | 329.84% |
|
|
|||||